A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2011
11/24/2011	US20110288167 Butylphthalide Intravenous Emulsion and Application Thereof
11/24/2011	US20110288166 Triptolide c-ring derivatives as anticancer agents and immune modulators
11/24/2011	US20110288165 Novel lipid composition for the treatment of skin problems in companion animals
11/24/2011	US20110288164 Agent for inhibiting production of hepatitis c virus and its use
11/24/2011	US20110288163 Methods of using macrocyclic modulators of the ghrelin receptor
11/24/2011	US20110288162 Transition metal complexes of a bis[thio-hydrazide amide] compounds
11/24/2011	US20110288161 Methods for treatment of thiol-containing compound deficient conditions
11/24/2011	US20110288159 Methods of expressing a polypeptide in the brain and nucleic acid constructs capable of same
11/24/2011	US20110288158 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
11/24/2011	US20110288157 RNAi-Mediated Inhibition of Spleen Tyrosine Kinase-Related Inflammatory Conditions
11/24/2011	US20110288156 Nucleic Acids, Polypetides, and Methods for Modulating Apoptosis
11/24/2011	US20110288155 Sirna compounds and methods of use thereof
11/24/2011	US20110288154 RNA Interference Mediated Inhibition of Epithelial Sodium Channel (ENaC) Gene Expression Using Short Interfering Nucleic Acid (siNA)
11/24/2011	US20110288153 Translation factors as anti-aging drug targets
11/24/2011	US20110288152 Psma binding ligand-linker conjugates and methods for using
11/24/2011	US20110288151 Methods of characterizing breast cancer and identifying treatments for same
11/24/2011	US20110288150 Oligonucleotides for Suppressing Cancer Cell Invasion and Migration
11/24/2011	US20110288149 Method of protecting against heart failure
11/24/2011	US20110288148 Triggered covalent probes for imaging and silencing genetic expression
11/24/2011	US20110288147 Compositions and methods for the specific inhibition of gene expression by DSRNA containing a tetraloop
11/24/2011	US20110288146 Directly compressible granular microcrystalline cellulose based, excipient, manufacturing process and use thereof
11/24/2011	US20110288145 Novel Formulation For L-Tryptophane Comprising Carbidopa/Benserazide
11/24/2011	US20110288144 Use of hdac inhibitors for the treatment of melanoma
11/24/2011	US20110288143 Bladder cancer treatment and methods
11/24/2011	US20110288142 CRYSTALLINE N--5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride
11/24/2011	US20110288141 Local topical administration formulations containing fipronil
11/24/2011	US20110288140 Treating inflammation and inflammatory pain in mucosa using mucosal prolonged release bioadhesive therapeutic carriers
11/24/2011	US20110288139 Substituted amino-benzimidazoles, medicaments comprimising said compound, their use and their method of manufacture
11/24/2011	US20110288138 Orally disintegrating tablets of zolmitriptan and process for preparing the same
11/24/2011	US20110288137 Sydnonimines-specific dopamine reuptake inhibitors ad their use in treating dopamine related disorders
11/24/2011	US20110288136 Flavivirus inhibition by sultams and related compounds
11/24/2011	US20110288135 Fast Dissolving Tablet
11/24/2011	US20110288134 Composition and method for treating fibrosis
11/24/2011	US20110288133 Histone deacetylase inhibitors
11/24/2011	US20110288132 Nicotine and Cocoa Powder Compositions
11/24/2011	US20110288130 Bacterial thioredoxin reductase inhibitors and methods for use thereof
11/24/2011	US20110288129 Amide derivatives as trpv1 antagonists
11/24/2011	US20110288128 Oral Transmucosal Administration of Sufentanil
11/24/2011	US20110288127 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
11/24/2011	US20110288126 Substituted dioxopiperidinyl phthalimide derivatives
11/24/2011	US20110288125 Novel use of piperine
11/24/2011	US20110288124 Compositions and method for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
11/24/2011	US20110288123 Formulations for the treatment of acute herpes zoster pain
11/24/2011	US20110288122 Pharmaceutical Compositions and Administrations Thereof
11/24/2011	US20110288121 Processes for Producing Modulators of Cystic Fibrosis Transmembrane Conductance Regulator
11/24/2011	US20110288120 Isoquinolinone derivatives as nk3 antagonists
11/24/2011	US20110288119 Low dose - prov (alpha 7-EVP)
11/24/2011	US20110288118 Pharmaceutical composition comprising solifenacin
11/24/2011	US20110288117 Substituted hydroxamic acids and uses thereof
11/24/2011	US20110288116 Iap inhibitors
11/24/2011	US20110288115 Treatment of vagally-mediated spectrum disorders
11/24/2011	US20110288114 Compositions for the treatment of fibrotic diseases or conditions
11/24/2011	US20110288113 Method to reduce or elminate the use by a patient of a tolerance-inducing pharamacological agent
11/24/2011	US20110288112 Method of Providing Sustained Analgesia With Buprenorphine
11/24/2011	US20110288111 Inhibition of influenza m2 proton channel
11/24/2011	US20110288110 Methods for treating disorders associated with hyperlipidemia in a mammal
11/24/2011	US20110288109 New compounds
11/24/2011	US20110288108 Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof
11/24/2011	US20110288107 Topical formulation for a jak inhibitor
11/24/2011	US20110288106 Adenine receptor ligands
11/24/2011	US20110288105 Eltoprazine for the treatment of l-dopa-induced dyskinesia
11/24/2011	US20110288104 Beta-3 receptor ligands and their use in therapy
11/24/2011	US20110288103 Compounds, compositions, and methods comprising 1,3,4-oxadiazole derivatives
11/24/2011	US20110288102 Il-8 biomarker for monitoring cancer treatment
11/24/2011	US20110288101 Surgical compositions containing sigma-receptor agonists
11/24/2011	US20110288100 Therapeutic agents useful for treating pain
11/24/2011	US20110288099 Compositions with reduced hepatotoxicity
11/24/2011	US20110288098 Novel compounds
11/24/2011	US20110288097 Pyrrolopyrazine Kinase Inhibitors
11/24/2011	US20110288096 Methods and compositions for treating or preventing erythema
11/24/2011	US20110288095 Thiophene-carboxamides useful as inhibitors of protein kinases
11/24/2011	US20110288094 1-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds having analgesic and/or immuno stimulant activity
11/24/2011	US20110288093 Compounds, Compositions, and Methods Comprising Pyridazine Sulfonamide Derivatives
11/24/2011	US20110288092 Heterocyclic Inhibitors of MEK and Methods of Use Thereof
11/24/2011	US20110288091 Soluble mtor complexes and modulators thereof
11/24/2011	US20110288090 Inhibitors of AKT Activity
11/24/2011	US20110288088 Substituted pyrrolo-pyrazole derivatives active as kinase inhibitors
11/24/2011	US20110288087 Fused ring compound and use thereof
11/24/2011	US20110288086 Polycyclic quinazolines, preparation thereof, and use thereof
11/24/2011	US20110288085 Imidazopyridine and imidazopyrazine compounds useful as kinase inhibitors
11/24/2011	US20110288084 [4-( 1-amino-ethyl) - cyclohexyl ] - methyl - amines as antibacterials
11/24/2011	US20110288083 Method of treating cancer by inhibition of protein kinase-like endoplasmic reticulum protein kinase
11/24/2011	US20110288082 Methods and compositions for inhibition of the transitional endoplasmic reticulum atpase
11/24/2011	US20110288081 Pyrimidine compounds and uses thereof
11/24/2011	US20110288080 Nitrofuran Compounds for the Treatment of Cancer and Angiogenesis
11/24/2011	US20110288079 Tannate Compositions, Methods of Making and Methods of Use
11/24/2011	US20110288078 Pyrazinopyrazines and derivatives as kinase inhibitors
11/24/2011	US20110288077 Compounds for the treatment of inflammatory diseases
11/24/2011	US20110288076 Sphingosine-1-Phosphate Receptor Antagonists
11/24/2011	US20110288075 Pyridazinone Derivatives
11/24/2011	US20110288074 New adenosine receptor ligands and uses thereof
11/24/2011	US20110288073 Alpha-Aminocyclolactam Ligands for G-protein Coupled Receptors, and Methods of Using Same
11/24/2011	US20110288072 Use of ivabradine for obtaining medicaments intended for the treatment of endothelial dysfunction
11/24/2011	US20110288071 Substituted pyrimidines for the treatment of diseases such as cancer
11/24/2011	US20110288070 Methods for treating cognitive disorders using inhibitors of histone deacetylase
11/24/2011	US20110288069 Benzodiazepine and Pyridodiazepine Derivatives
11/24/2011	US20110288068 Aza spiro alkane derivatives as inhibitors of metalloproteases
11/24/2011	US20110288067 Pyrrolopyrazine Kinase Inhibitors
11/24/2011	US20110288066 Phenoxy acetic acid derivatives
11/24/2011	US20110288065 Aminopyrazine derivative and medicine

1 ... 1467 1468 1469 1470 1471 1472 1473 1474 1475 1476 1477 1478 1479 1480 1481 1482 1483 1484 1485 1486 1487 ... 7860